Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 1/2009

01-02-2009 | CE - Letter to the Editor

Egg white injury

Authors: Lisa Cammalleri, Prospera Bentivegna, Mariano Malaguarnera

Published in: Internal and Emergency Medicine | Issue 1/2009

Login to get access

Excerpt

A 66-year-old man was admitted to our Department for a sudden loss of consciousness, tonic–clonic movement and psychomotor agitation. During the previous 4 months the patient had complained of drowsiness, fatigue, lack of appetite, and nausea. During the prior 2 months he had experienced hair loss, coating of the tongue, and skin flaking with pruritus. …
Literature
1.
Gyorgy P, Kuhn R, Lederer E (1939) The curative factor (vitamin H9 for egg white injury, with particular reference to its presence in different foods tuffs and yeast. J Biol Chem 131:733–744
2.
Dakshinamurti K, Li W (1994) Transcriptional regulation of liver phosphoenolpyruvate carboxykinase by biotin in diabetic rats. Mol Cell Biochem 132:127–132PubMedCrossRef
3.
Koutsikos D, Agroyannis B, Tzanatos-Exarchou H (1990) Biotin for diabetic peripheral neuropathy. Biomed Pharmacother 44:511–514PubMedCrossRef
4.
Taitz LS, Leonard JV, Bartlett K (1985) Long-term auditory and visual complications of biotinidase deficiency. Early Hum Dev 11:325–331PubMedCrossRef
5.
Weber P, Scholl S, Baumgartner ER (2004) Outcome in patients with profound biotinidase deficiency: relevance of newborn screening. Dev Med Child Neurol 46:481–484PubMedCrossRef
6.
Paulose CS, Thliveris T, Viswanathan M, Dakshinamurti K (1989) Testicular function in biotin-deficient adult rats. Horm Metab Res 21:661–665PubMedCrossRef
7.
Zempleni J (1999) Mock DM: bioavailability of biotin given orally to humans in pharmacologic doses. Am J Clin Nutr 69:504–508PubMed
8.
Seymons K, De Moor A, De Raeve H, Lambert J (2004) Dermatologic signs of biotin deficiency leading to the diagnosis of multiple carboxylase deficiency. Pediatr Dermatol 21:231–235PubMedCrossRef
9.
Zempleni J (1998) Mock DM: uptake and metabolism of biotin by human peripheral blood mononuclear cells. AmJ Physiol 275:C382–C388
10.
Mardach R, Zempleni J, Wolf B, Cannon MJ, Jennings ML, Cress S, Boylan J, Roth S, Cederbaum S, Mock DM (2002) Biotin dependency due to a defect in biotin transport. J Clin Invest 109:1617–1623PubMed
11.
Krause KH, Berlit P, Bonjour JP, Schmidt-Gayk H, Schellenberg B, Gillen J (1982) Vitamin status in patients on chronic anticonvulsant therapy. Int J Vitam Nutr Res 52:375–385PubMed
12.
Sealey WM, Stratton SL, Mock DM, Hansen DK (2005) Marginal maternal biotin deficiency in CD-1 mice reduces fetal mass of biotin-dependent carboxylases. J Nutr 135:973–977PubMed
Metadata
Title
Egg white injury
Authors
Lisa Cammalleri
Prospera Bentivegna
Mariano Malaguarnera
Publication date
01-02-2009
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 1/2009
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-008-0192-5

Other articles of this Issue 1/2009

Internal and Emergency Medicine 1/2009 Go to the issue

IM - Physical Examination

Which test, coronary angiography or colonoscopy?

EM - Commentary

Not the end of end-tidal CO2

CE - Letter to the Editor

An uncommon cause of acute severe respiratory failure: a case report

CE - Letter to the Editor

Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?

CE - Letter to the Editor

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients

CE - Letter to the Editor

Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits